BCYC
Bicycle Therapeutics Ltd
3.70$
-1.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +328.7% | -40.8% | -3.1% | -34.3% | +504.0% | -76.2% | -59.7% | +760.1% | -78.6% | +39.1% | +144.6% | +0.2% | -53.0% | -1.3% | +142.7% | -13.0% | +2.4% | +13.4% | -30.6% | +4.8% | +53.7% | +132.8% | -53.0% | -0.4% | +266.3% | -52.1% | -71.4% | +38.6% | +169.1% | -70.7% | +301.8% | +308.7% | -98.2% | -29.1% | – | |
| – | -9.6% | +32.6% | +14.7% | +15.1% | -3.3% | +4.2% | -7.0% | +9.4% | +16.9% | +2.4% | -7.5% | +36.6% | -3.6% | +17.0% | -10.7% | +37.3% | -2.9% | +35.6% | +17.0% | -93.5% | +12.5% | +5.0% | +9,086.6% | -98.9% | -0.7% | -0.9% | +2,680.3% | +22.8% | +2.1% | +24.0% | – | – | – | – | – | |
| – | – | – | – | – | – | -4,743.5% | – | – | – | – | +144.6% | -261.6% | – | -1.3% | +142.7% | -13.0% | +2.4% | +13.4% | -30.6% | +4.8% | +53.7% | +132.8% | -53.0% | -0.4% | +266.3% | -52.1% | -559.1% | – | – | – | – | +308.7% | -98.2% | -29.1% | – | |
| – | -46.8% | +32.6% | +14.7% | +15.1% | -3.3% | +4.2% | -7.0% | +38.2% | +15.6% | -18.1% | -7.5% | +77.9% | -26.0% | +20.9% | -10.3% | +23.2% | +10.3% | +39.0% | +14.6% | +8.6% | +30.3% | +23.3% | +0.4% | +12.1% | -22.0% | +14.9% | +20.5% | +3.1% | +18.6% | +20.3% | -17.7% | -11.4% | -5.5% | -15.8% | – | |
| – | -22.6% | -14.4% | +36.6% | -9.4% | +61.5% | -12.6% | +61.1% | -29.1% | +47.2% | +25.9% | +1.8% | +69.4% | -25.4% | -9.3% | +12.6% | +5.5% | +93.1% | -33.8% | -8.0% | +4.6% | +31.0% | +8.1% | +2.6% | -3.3% | +9.3% | -2.4% | +13.8% | +15.1% | +0.5% | -8.9% | -1.1% | +9.6% | -15.7% | -20.2% | – | |
| – | +138.5% | +16.2% | +20.4% | +7.9% | +12.5% | -1.7% | +14.3% | -68.7% | +47.2% | +183.2% | +2.6% | -25.3% | +64.4% | +6.9% | -2.3% | +17.0% | +43.3% | +1.4% | +3.5% | +7.9% | +31.9% | +16.7% | +3.0% | +6.1% | -14.0% | +9.3% | -62.7% | -26.7% | +49.7% | -19.3% | +317.9% | -6.0% | -8.5% | -17.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | +75.0% | -80.6% | +506.9% | +19.5% | +56.9% | +0.5% | -0.4% | -0.2% | +7.9% | -7.5% | +1.1% | -2.2% | +1.6% | -0.9% | +0.7% | +0.1% | +0.4% | -96.0% | +57.6% | -1.9% | +5.9% | -18.5% | +29.5% | -15.8% | -8.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4,500.0% | – | – | – | – | +68.8% | -345.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -85.9% | -209.4% | – | -3,098.3% | – | – | – | – | +517.1% | -86.4% | -47.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.